Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abacavir for HIV-1-associated AIDS dementia complex
ISRCTN53707238Phase 3Completed
- Sponsor
- GSK
- Start
- Sep 1996
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of abacavir in Human immunodeficiency virus infection type 1 and AIDS Dementia Complex (HAD) (3 arms), sponsored by GSK. Primary endpoint: Improvement in neuropsychological performance. Started Sep 1996; status: completed.
02
Drugs
abacavir
03
Conditions
Human immunodeficiency virus infection type 1AIDS Dementia Complex (HAD)
Beyond the preview
Go deeper on ISRCTN53707238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN53707238.